Radiopharmaceutical Therapies: 177Lu-Dotatate and 177Lu-PSMA-617
Radiopharmaceutical therapies have been a breakthrough cancer treatment for tumors resistant to cytotoxic chemotherapy and many new radiopharmaceutical agents are in active development.
Category
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice.
Category
  • Professional Development
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
eContouring for Breast Cancer Webinar
This eContouring Webinar on breast cancer is an interactive, case-based educational session designed to strengthen breast radiation therapy contouring skills. The session emphasizes treatment planning strategies, practical anatomy, and variations in current contouring guidelines.
Category
  • Breast
Format
  • Upcoming Webinar
  • Webinars
  • eContouring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $179.00
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
Increasing evidence has demonstrated the importance of immunomodulation on tumor control. Radiotherapy, specifically, can produce a multitude of local and systemic immunomodulatory effects, including reprogramming the tumor microenvironment and exposing tumor antigens via in situ vaccination.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00

Pages